Abstract:Abstract Malignant melanoma is a deadly skin cancer with poor prognosis if not diagnosed early and treated before metastasis occurs. Chemotherapy is often ineffective primarily due to the cancer cell's intrinsic resistance to current therapeutic agents like Dacarbazine and BCNU. Hence, it is important to identify new agents that would be effective in killing malignant melanoma cells. The naturally occurring small molecule, OSW-1 ((3 beta, 16 beta, 17 alpha-trihydroxycholest-5-en-22 - one 16-O-(2-O-4-methoxybenzoyl-beta-D-xylopyranosyl)-(1→3)-(2-O-acetyl-alpha-L arabinopyranoside) isolated from the bulbs of ivory coast lily (O. saudersiae) has been shown to be highly cytotoxic in numerous cancer cell lines with yet undefined mechanisms of action. Herein, we report results of our study on the anticancer activity and selectivity of OSW-1 in malignant melanoma cells and its potential mechanism of action. OSW-1 was highly antiproliferative in malignant melanoma cells, and its cytotoxic effect was time- and concentration-dependent, with the IC50 value below 1 nM. Importantly, OSW-1 preferentially killed melanoma cells and exerted much lower toxicity to normal melanocytes in culture. Also, this inhibitory activity was more pronounced in highly metastatic melanoma cells compared to the less invasive ones. Using an isogenic pair of melanoma cells with different Akt activation states, we observed that cells with higher Akt expression (metastatic cells) exhibited less spontaneous cell death in culture, but were significantly more sensitive to OSW-1 than cells with lower basal levels of phosphorylated Akt (noninvasive cells). Biochemical analysis with Rhodamine-123 indicated that OSW-1 stimulated cell death by damaging mitochondrial membrane integrity, leading to a decrease in transmembrane potential and subsequently initiating cell death, apparently through autophagy. This was confirmed by western blot analysis of the lipidation of LC3 after drug treatment. Interestingly, a combination of OSW-1 and chloroquine, a lysosomotropic agent known to promote rapid apoptosis in autophagic cells, resulted in a synergistic cytotoxic effect with a two-fold increase in cell death, which occurred much faster than in cells treated with either compound alone. The mode of cell death appeared to be shifted toward apoptosis. Western blots from cells treated with the drug combination showed an increase in the levels of caspase-3 activation. Further biochemical study suggested that OSW-1 might cause a significant disturbance of cellular calcium homeostasis, leading to aberrant calcium-mediated processes including mitochondrial impairment. We postulate that an abnormally high level of phosphorylated Akt could lead to mitochondrial dysfunction and deregulation of calcium homeostasis in malignant melanoma cells, and thus render them more vulnerable to OSW-1. Further work is needed to elucidate the detailed signaling pathways and molecular mechanisms. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 101st Annual Meeting of the American Association for Cancer Research; 2010 Apr 17-21; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2010;70(8 Suppl):Abstract nr 3567.

Identification of unique sensitizing targets for anti-inflammatory CDDO-Me in metastatic melanoma by a large-scale synthetic lethal RNAi screening.

Abstract 1833: A large-scale synthetic lethal RNAi screening identifies unique sensitizing targets for anti-inflammatory CDDO-Me in metastatic melanoma

Regulatory Role of Methionine Enkephalin in Myeloid-Derived Suppressor Cells and Macrophages in Human Cutaneous Squamous Cell Carcinoma.

Dissection of stromal and cancer cell-derived signals in melanoma xenografts before and after treatment with DMXAA

Toxicogenomic and bioinformatics platforms to identify key molecular mechanisms of a curcumin-analogue DM-1 toxicity in melanoma cells

A Comprehensive Proteogenomic and Spatial Analysis of Innate and Acquired Resistance of Metastatic Melanoma to Immune Checkpoint Blockade Therapies

Screening Genes Associated with Melanoma Using a Combined Analysis of Mrna and Methylation Microarray

Causal-inferring and molecular-docking yield new targets for malignant melanoma therapy

Isothiocyanates Potentiate Tazemetostat-Induced Apoptosis by Modulating the Expression of Apoptotic Genes, Members of Polycomb Repressive Complex 2, and Levels of Tri-Methylating Lysine 27 at Histone 3 in Human Malignant Melanoma Cells

Synergistic anti-tumor activity and inhibition of angiogenesis by cotargeting of oncogenic and death receptor pathways in human melanoma

Defining melanoma combination therapies that provide senolytic sensitivity in human melanoma cells

Clarifying new molecular subtyping and precise treatment of melanoma based on disulfidptosis-related lncRNA signature

Dendritic Cell-Derived Exosomes Driven Drug Co-Delivery Biomimetic Nanosystem for Effective Combination of Malignant Melanoma Immunotherapy and Gene Therapy

System analysis based on the pyroptosis-related genes identifes GSDMD as a novel therapy target for skin cutaneous melanoma

Identification of potential therapeutic targets for skin cutaneous melanoma on the basic of transcriptomics

Senescence-associated secretory factors induced by cisplatin in melanoma cells promote non-senescent melanoma cell growth through activation of the ERK1/2-RSK1 pathway

Integrated transcriptomic and immunological profiling reveals new diagnostic and prognostic models for cutaneous melanoma

Gene Identification and Potential Drug Therapy for Drug-Resistant Melanoma with Bioinformatics and Deep Learning Technology

Screening and identification of potential biomarkers and therapeutic drugs in melanoma via integrated bioinformatics analysis

Inhibitory Effects and Mechanisms of the Novel Shikonin Derivative DMAKO-20 on Melanoma Metastasis and Invasion

Abstract 3567: the Antitumor Agent OSW-1 in Melanoma Therapy : an Insight